MGA Home Healthcare Colorado, LLC v. Thun

CourtDistrict Court, D. Colorado
DecidedMay 23, 2023
Docket1:22-cv-02534
StatusUnknown

This text of MGA Home Healthcare Colorado, LLC v. Thun (MGA Home Healthcare Colorado, LLC v. Thun) is published on Counsel Stack Legal Research, covering District Court, D. Colorado primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
MGA Home Healthcare Colorado, LLC v. Thun, (D. Colo. 2023).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO Judge Nina Y. Wang

Civil Action No. 22-cv-02534-NYW-STV

MGA HOME HEALTHCARE COLORADO, LLC,

Plaintiff,

v.

SHEA THUN,

Defendant.

ORDER

This matter is before the Court on two motions: (1) Plaintiff MGA Home Healthcare Colorado, LLC’s (“MGA” or “Plaintiff”) Motion for Leave to File a Verified First Amended Complaint for Preliminary and Permanent Injunction (“Motion to Amend” or “Motion”) [Doc. 28, filed January 27, 2023]; and (2) Defendant Shea Thun’s (“Mr. Thun” or “Defendant”) Motion for Declaratory Judgment Related to Superseding Agreement (“Motion for Declaratory Judgment” and, collectively, the “Motions”) [Doc. 39, filed April 3, 2023]. Upon review of the Motions, the related briefing, and the applicable case law, the Motion to Amend is respectfully DENIED as moot, and the Motion for Declaratory Judgment is respectfully DENIED. BACKGROUND I. Factual Background This case arises out of the former employment relationship between MGA and Mr. Thun. See [Doc. 1]. As alleged in the Complaint, Mr. Thun was employed as a Lead Client Service Manager at MGA from July 2018 to February 2022. [Id. at ¶¶ 9–10, 21]. In that role, Mr. Thun “was privy to MGA’s highly confidential information, trade secret, employee compensation, customer contact, and service pricing information.” [Id. at ¶ 10]. Mr. Thun’s Employment

Agreement contained provisions to protect MGA’s confidential information during the course of his employment and after it ended, including that, for 12 months after his employment ended, he would not solicit any of MGA’s customers or employees (“Restrictive Covenants”). [Id. at ¶¶ 11– 14]. When Mr. Thun was terminated in February 2022, he signed a Severance Agreement wherein he agreed that he did not possess or control any of MGA’s property, he was complying with the Restrictive Covenants in his Employment Agreement, and he would continue to do so. [Id. at ¶ 22]. MGA alleges that, “[d]espite the express terms of the Employment Agreement and [Mr.] Thun’s reaffirmation and acknowledgement of those terms in the Solicitation Agreement, [Mr.] Thun has solicited MGA’s employees and customers while working for” his new employer,

Amazing Care Home Health Services, LLC (“Amazing Care”). [Id. at ¶¶ 23–24]. Specifically, MGA claims that it received a text message from a caregiver explaining that she was offered a position at Amazing Care by Mr. Thun. Thun offered the caregiver a wage of $19.50 per hour, a higher rate than offered by MGA and the caregiver left MGA’s employment and is now working for Amazing Care. [Id. at ¶ 28]. MGA also alleges that Mr. Thun “never responded” to two cease-and-desist letters. [Id. at ¶¶ 25, 27]. In the Complaint, MGA asserts three claims against Mr. Thun: (1) violation of the Defend Trade Secrets Act (“DTSA”), 18.U.S.C. § 1839 (Count I); (2) violation of the Colorado Uniform Trade Secrets Act (“CUTSA”), Colo. Rev. Stat. § 7-74-101, et seq. (Count II); and (3) breach of contract (Count III). [Id. at 8–12]. MGA seeks monetary and injunctive relief in the form of an order directing Mr. Thun to return MGA’s confidential information, prohibiting him from using that confidential information further, and requiring him to provide a list of all MGA patients he contacted since his termination. [Id. at 12–13].

II. Procedural Background MGA initiated this civil action against Mr. Thun on September 28, 2022 by filing the Complaint, [Doc. 1], and a Motion for Preliminary Injunction (“PI Motion”), [Doc. 2]. On November 21, 2022, the Court held a telephonic status conference regarding the PI Motion, where the Parties indicated that they had been, or were intending to, engage in settlement discussions. See [Doc. 15 at 1]. However, if the Parties were unable to resolve the case by December 7, 2022, the Court directed them to include in their proposed Scheduling Order a briefing schedule for the PI Motion. [Id. at 1–2]. After the Parties were unable to reach a settlement, they agreed that Defendant’s response to the PI Motion would be due on January 13, 2023, and Plaintiff’s reply brief would be due on January 27, 2023. [Doc. 25 at 11–12]. Accordingly, Mr. Thun responded

to the PI Motion on January 12, 2023, [Doc. 27], and MGA replied on January 27, 2023, [Doc. 29]. The same day, MGA filed the instant Motion to Amend. [Doc. 28]. On February 7, 2023, the Court held a hearing where it set a briefing schedule on the Motion to Amend, and an evidentiary hearing on the PI Motion for April 14, 2023. See [Doc. 31]. However, MGA ultimately withdrew the PI Motion. See [Doc. 37; Doc. 41]. Mr. Thun responded to the Motion to Amend on February 17, 2023, [Doc. 33], and MGA replied on March 3, 2023. [Doc. 34].1 Mr. Thun filed the Motion for Declaratory Judgment on April 3, 2023, which is also fully briefed. See [Doc. 39; Doc. 44; Doc. 47]. The Motions are thus ripe for disposition.

1 At a Scheduling Conference on May 4, 2023, the Parties agreed to a deadline of June 16, 2023 LEGAL STANDARDS I. Rule 15(a) When, as here, a party seeks to amend pleadings before the deadline set in the Scheduling Order, the Court considers whether amendment is proper under Rule 15(a) of the Federal Rules of

Civil Procedure. See Gorsuch, Ltd., B.C. v. Wells Fargo Nat. Bank Ass’n, 771 F.3d 1230, 1240– 42 (10th Cir. 2014); Pumpco, Inc. v. Schenker Int’l, Inc., 204 F.R.D. 667, 668 (D. Colo. 2001). Rule 15(a) provides that leave to amend “shall be freely given when justice so requires.” Fed. R. Civ. P. 15(a)(2). Refusing leave to amend is generally only justified upon a showing of undue delay, undue prejudice to the opposing party, bad faith or dilatory motive, failure to cure deficiencies by amendments previously allowed, or futility of amendment. See Pumpco, 204 F.R.D. at 668; Frank v. U.S. West, Inc., 3 F.3d 1357, 1365 (10th Cir. 1993). The party contesting the motion to amend has the burden of proving that the amendment should be refused on one of these bases. See Acker v. Burlington N. & Santa Fe R. Co., 215 F.R.D. 645, 654 (D. Kan. 2003). Whether to allow amendment is within the trial court’s discretion. Burks v. Okla. Publ’g Co., 81

F.3d 975, 978–79 (10th Cir. 1996). II. Rule 57 Rule 57 of the Federal Rules of Civil Procedure provides:

These rules govern the procedure for obtaining a declaratory judgment under 28 U.S.C. §2201. Rules 38 and 39 govern a demand for a jury trial. The existence of another adequate remedy does not preclude a declaratory judgment that is otherwise appropriate. The court may order a speedy hearing of a declaratory-judgment action.

Fed. R. Civ. P. 57. But it is well-settled that the Declaratory Judgment Act, and Rule 57, do not provide an independent federal cause of action or create any additional substantive rights. See

to amend their pleadings. [Doc. 45 at 11; Doc. 49 at 11]. Nero v. Oklahoma, No. 22-6121, 2022 WL 14423872, at *2 (10th Cir. Oct. 25, 2022) (citing Skelly Oil Co. v. Phillips Petrol. Co., 339 U.S. 667

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Skelly Oil Co. v. Phillips Petroleum Co.
339 U.S. 667 (Supreme Court, 1950)
Phillips v. Hillcrest Medical Center
244 F.3d 790 (Tenth Circuit, 2001)
Tal v. Hogan
453 F.3d 1244 (Tenth Circuit, 2006)
United States v. Davis
622 F. App'x 758 (Tenth Circuit, 2015)
Pumpco, Inc. v. Schenker International, Inc.
204 F.R.D. 667 (D. Colorado, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
MGA Home Healthcare Colorado, LLC v. Thun, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mga-home-healthcare-colorado-llc-v-thun-cod-2023.